Charles River Laboratories | CRL - Operating Expenses


Charles River Laboratories reported $2.84B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Agilent USD 1.43B 2M Jun/2026
Align Technology USD 864.87M 2.84M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Cardinal Health USD 62.86B 65.69B Jun/2026
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Cigna USD 42.62B 410M Jun/2026
Concord Medical Services Hldg CNY 354.58M 9.32M Dec/2025
CVS Health USD 99.37B 3.62B Jun/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.35B 33M Jun/2026
Elevance Health USD 49.28B 4.39B Sep/2026
Humana USD 39.51B 1.61B Jun/2026
Illumina USD 899M 47M Jun/2026
Incyte USD 973.64M 4.65B Jun/2026
Intrexon USD 61.56M 26.1M Jun/2024
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Laboratory Of America USD 3.27B 146.9M Jun/2026
Lakefront Biotherapeutics EUR 55.62M 14.56M Jun/2026
Lonza CHF 2.9B 184M Jun/2025
McKesson USD 103.96B 9.5B Jun/2026
Merck EUR 4.34B 249M Jun/2026
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Quest Diagnostics USD 2.62B 34M Sep/2026
Revvity USD 603.55M 24.8M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
United Therapeutics USD 6.4B 499.2M Jun/2026
UnitedHealth USD 106.35B 2.31B Sep/2026
Veradigm USD 188M 61.08M Dec/2022
Waters USD 527M 592M Jun/2026
West Pharmaceutical Services USD 2.99B 200K Jun/2026